Being told you have gestational diabetes during pregnancy can feel frightening, but with the right clinical approach, it is a highly manageable condition. Gestational Diabetes Mellitus (GDM) typically develops during the second or third trimester when pregnancy hormones interfere with insulin function. In India, and specifically in urban centers like Chennai, women face a disproportionately high burden due to genetic predispositions and lifestyle shifts, with local prevalence rates reaching nearly 18%.
The primary goal of treatment is to protect both mother and baby from the complications of elevated blood glucose, such as excessive fetal growth or birth difficulties. Fortunately, most women can achieve healthy outcomes through a combination of medical nutrition therapy, structured physical activity, and diligent monitoring. This comprehensive guide explores the hormonal mechanisms of GDM, details evidence-based treatment pathways, from dietary adjustments to insulin therapy and outlines the essential steps for long-term postpartum health.
What Gestational Diabetes Is and Why India Faces a Particularly High Burden
Gestational diabetes mellitus (GDM) is a form of diabetes that develops during pregnancy, typically in the second or third trimester, in women who did not have diabetes before conception. It occurs when pregnancy hormones impair the body's ability to use insulin effectively, causing blood glucose levels to rise above the safe range for pregnancy.
India carries one of the highest GDM burdens globally. According to research published in NCBI, the prevalence of GDM in India ranges from 7.7% to 21.6% in urban populations. The Chennai picture is particularly significant. A large community-based study published in PubMed found that GDM was detected in 17.8% of pregnant women in urban Chennai, making it among the highest documented urban prevalences in the country.
South Asian women, including Indian women, carry a genetic predisposition to insulin resistance that makes them more susceptible to GDM even at lower body weight thresholds than women of European origin. Combined with rapid urbanisation, high-carbohydrate diets, sedentary lifestyles, and increasing rates of PCOS and obesity among women of reproductive age, the GDM burden in Chennai is significant, growing, and demands active management.
The good news: GDM is one of the most manageable pregnancy complications when identified early and treated correctly. After diagnosis, treatment starts with medical nutrition therapy, physical activity, and weight management, as well as glucose monitoring. This guide explains each component of treatment clearly.
Why GDM Happens: The Hormonal Mechanism
Understanding why GDM develops helps explain why every treatment approach works the way it does.
During pregnancy, the placenta produces hormones including human placental lactogen, oestrogen, progesterone, and cortisol. These hormones are essential for fetal development but they progressively increase insulin resistance in the mother's tissues, particularly from the second trimester onward. This is a normal physiological process. In most pregnancies, the mother's pancreas compensates by producing more insulin.
In women who develop GDM, the pancreas cannot compensate adequately. Blood glucose rises. The fetus, exposed to the mother's elevated glucose, responds by producing more insulin itself. This results in excessive fetal growth (macrosomia), altered fetal metabolism, and a range of complications that are entirely preventable with well-managed maternal blood glucose.
This is why glucose targets during pregnancy are stricter than in non-pregnant diabetes management. Consistently keeping blood glucose within the recommended range during pregnancy protects the fetus from the downstream consequences of maternal hyperglycaemia.
Who Is at Higher Risk of GDM in India
Several risk factors significantly increase the likelihood of GDM, and a number of these are disproportionately prevalent in urban Indian women:
According to a 2024 study published in NCBI, the risk factors most consistently associated with GDM in Indian women include obesity, sedentary lifestyle, poor dietary habits, advanced maternal age, family history of diabetes, and previous history of GDM or macrosomic infants.
Additional India-specific risk factors include:
-
PCOS: Polycystic ovary syndrome, which is highly prevalent in Indian women of reproductive age, is independently associated with elevated GDM risk through pre-existing insulin resistance.
-
Genetic predisposition: South Asian ethnic background independently increases insulin resistance risk, making Indian women more susceptible to GDM at lower BMI values than Western populations.
-
Previous large baby: A baby weighing more than 3.5 kg in a previous pregnancy suggests the mother had undiagnosed or managed GDM in that pregnancy. Family history of Type 2 diabetes: A first-degree relative with Type 2 diabetes significantly elevates GDM risk.
-
Age above 25: A community-based study in Tamil Nadu found that age above 25 and BMI above 25 were independent risk factors for GDM.
If any of these apply to you, GDM screening earlier in pregnancy (from the first trimester rather than the standard 24 to 28 weeks) is warranted and should be discussed with your obstetrician.
How Gestational Diabetes Is Diagnosed
The standard screening test for GDM is the Oral Glucose Tolerance Test (OGTT), most commonly performed between 24 and 28 weeks of gestation for women without known risk factors. Women with risk factors are screened earlier.
During the OGTT, you drink a solution containing 75 grams of glucose. Blood samples are taken at fasting, one hour, and two hours after the drink. GDM is diagnosed when any one of the following thresholds is met or exceeded:
-
Fasting: 92 mg/dL or above
-
1 hour: 180 mg/dL or above
-
2 hours: 153 mg/dL or above
These are the internationally used IADPSG (International Association of Diabetes and Pregnancy Study Groups) diagnostic thresholds, also adopted by leading Indian obstetric guidelines.
An abnormal result at any single time point is sufficient for a GDM diagnosis. A positive diagnosis does not mean your pregnancy is immediately in danger. It means your management plan needs to change, beginning with the treatments described below.
Treatment 1: Medical Nutrition Therapy The Foundation of GDM Management
Medical nutrition therapy (MNT) is the starting point for every woman with GDM. For many women with mild GDM, MNT alone achieves adequate blood glucose control throughout pregnancy without medication.
The principles of GDM nutrition therapy, tailored to the Indian dietary context, include:
-
Carbohydrate distribution, not elimination: The goal is not to stop eating carbohydrates but to distribute them across three main meals and two to three snacks throughout the day. Spreading carbohydrate intake prevents the blood glucose spikes that follow large meals. A sudden large plate of rice or roti delivers far more glucose into the bloodstream in a short time than the same total carbohydrate spread across two smaller servings.
-
Choosing lower glycaemic index carbohydrates: White rice and refined flour (maida) raise blood glucose rapidly. Alternatives including unpolished red rice, small quantities of brown rice, whole grain rotis, millets (ragi, jowar, bajra), oats, and dal and legumes raise blood glucose more slowly, reducing postprandial spikes. This does not mean eliminating rice from an Indian diet. It means moderating portion size and pairing it with protein, fat, and fibre.
-
Prioritising protein and healthy fats: Including protein in every meal slows gastric emptying and blunts the postprandial glucose rise. Eggs, paneer, curd, pulses, fish, and chicken are appropriate protein sources. Including healthy fats such as ghee in modest amounts is preferable to removing fat entirely, as fat also slows glucose absorption.
-
Managing fruit intake: Fruits contain natural sugars and should be consumed in moderation and whole (not juiced). One small serving of low-glycaemic fruit such as guava, papaya, or apple at a time, consumed with a meal rather than alone, is a reasonable approach.
-
Avoiding sugar-sweetened beverages and processed foods: These cause rapid blood glucose spikes and provide no nutritional benefit in a GDM management plan. A registered dietitian with experience in GDM management, ideally one familiar with Indian food patterns, provides the most personalised and culturally appropriate nutrition plan.
Treatment 2: Physical Activity During Pregnancy
Physical activity is a clinically proven and underutilised component of gestational diabetes treatment. Exercise improves insulin sensitivity in the mother's muscles, reducing the amount of insulin needed to keep blood glucose within range.
As the American Diabetes Association's 2025 Standards of Care confirms, physical activity is recommended as a component of GDM management alongside nutrition therapy. For most pregnant women without obstetric contraindications, 30 minutes of moderate-intensity activity on most days of the week is appropriate.
Practical forms of activity suitable for pregnancy include:
-
Brisk walking after meals is particularly effective for lowering postprandial blood glucose
-
Prenatal yoga improves flexibility, reduces stress, and provides gentle aerobic benefit
-
Swimming is gentle on joints and highly effective for cardiovascular fitness during pregnancy
-
Stationary cycling provides aerobic benefit without impact
Physical activity should be discussed with the obstetrician before starting or increasing, particularly for women with obstetric complications or high-risk pregnancies. However, for the majority of women with GDM, structured movement after main meals is one of the most effective tools available for blunting postprandial glucose rises.
Treatment 3: Blood Glucose Monitoring
Consistent blood glucose monitoring is essential for both the woman with GDM and her healthcare team. It provides the data needed to determine whether nutrition and exercise alone are achieving adequate control, or whether medication is required.
The blood glucose targets recommended during pregnancy, as established by the Fifth International Workshop Conference on GDM and widely adopted in India, are:
-
Fasting blood glucose: below 95 mg/dL (5.3 mmol/L)
-
1-hour post-meal blood glucose: below 140 mg/dL (7.8 mmol/L)
-
2-hour post-meal blood glucose: below 120 mg/dL (6.7 mmol/L)
Self-monitoring typically involves testing fasting glucose each morning and glucose one or two hours after each main meal. This gives a picture of both overnight glucose patterns and the response to individual meals.
Continuous glucose monitoring (CGM) is increasingly used in GDM management. As the ADA's 2026 Standards of Care confirms, CGM provides more comprehensive glucose data than intermittent finger-prick testing and allows both the patient and clinician to identify patterns that inform dietary and activity adjustments in real time. It is particularly useful for women whose glucose control is borderline or who require insulin therapy.
Treatment 4: Insulin Therapy
When blood glucose targets are not achieved within 1 to 2 weeks of optimised nutrition and activity management, medication is required to protect both the mother and the baby.
Insulin is the preferred pharmacological treatment for GDM and has been used safely in pregnancy for decades. As confirmed by the ADA 2025 and 2026 Standards of Care, insulin does not cross the placenta and therefore directly affects only the mother's blood glucose without exposing the fetus to the medication.
The type of insulin prescribed (rapid-acting, long-acting, or a combination) and the injection schedule depend on where blood glucose is exceeding targets. Elevated fasting glucose typically requires a long-acting basal insulin (such as insulin detemir or NPH insulin) given at bedtime. Elevated post-meal glucose may require rapid-acting insulin (such as insulin aspart or regular human insulin) given before meals.
Insulin doses during pregnancy require ongoing adjustment because placental hormone production increases throughout the second and third trimesters, progressively increasing insulin resistance. Regular review and dose adjustment by a specialist, particularly a diabetologist with experience in gestational diabetes management, is essential throughout the treatment period.
Insulin initiation during pregnancy is not a failure of diet and exercise. It is a clinical decision based on blood glucose data, and it significantly reduces the risk of GDM complications for both mother and baby.
Treatment 5: Oral Medications
For women who are unable to tolerate or access insulin, oral medications may be considered.
-
Metformin: Metformin improves insulin sensitivity and reduces hepatic glucose production. It is increasingly used in GDM management globally and is considered an option when insulin is unavailable or unacceptable. However, metformin does cross the placenta, and its long-term effects on the child are still under investigation in some research contexts. The ADA 2026 Standards of Care acknowledges metformin as an option in appropriate clinical contexts.
-
Glyburide (Glibenclamide): Historically used as an alternative to insulin for GDM, glyburide has fallen out of favour in current guidelines due to evidence of higher rates of neonatal hypoglycaemia compared to insulin. Most current international guidelines, including the ADA, do not recommend glyburide as a first-line pharmacological option for GDM.
The decision about whether oral medication is appropriate is made in discussion with your obstetrician and diabetologist, accounting for the severity of glucose elevation, the specific pattern of hyperglycaemia, and individual clinical factors.
What Happens When GDM Goes Untreated or Poorly Controlled
Understanding what is at stake when blood glucose targets are consistently missed is important for motivating consistent treatment adherence.
For the baby, poorly controlled GDM increases the risk of macrosomia (excessively large birth weight), which complicates delivery and increases the risk of birth injuries; neonatal hypoglycaemia shortly after birth, as the baby's own insulin production remains elevated after the high-glucose environment ends; respiratory distress syndrome in the newborn; and, according to ADA 2026, offspring exposed to untreated GDM have reduced insulin sensitivity and are more likely to have impaired glucose tolerance in childhood.
For the mother, poorly controlled GDM increases the risk of preeclampsia, the need for caesarean section, and polyhydramnios (excess amniotic fluid). There is also a significant long-term risk: mothers who experience GDM have a 50 to 70% lifetime risk of developing Type 2 diabetes. This underscores why GDM management during pregnancy is also the beginning of a long-term health investment, not merely a temporary pregnancy complication.
After Delivery: The Postpartum Chapter
For most women, blood glucose returns to normal within days to weeks of delivery once the placenta is delivered and its hormone production ends. GDM is not permanent. However, the long-term risk it signals is real and deserves attention.
The ADA 2026 Standards of Care recommends that individuals with a history of GDM who are planning another pregnancy should undergo screening for Type 2 diabetes or prediabetes before conception. For women not planning immediate pregnancy, an OGTT at 6 to 12 weeks postpartum confirms whether blood glucose has normalised, followed by annual screening thereafter.
Breastfeeding is encouraged after GDM pregnancy. It benefits the infant's long-term metabolic health and is associated with reduced risk of Type 2 diabetes in the mother. Lifestyle modification, including healthy weight maintenance and regular physical activity after delivery, is the most effective long-term strategy for reducing the risk of Type 2 diabetes in women who have experienced GDM.
GDM Management at Dr. Humayun Speciality Hospital, T. Nagar, Chennai
At Dr. Humayun Speciality Hospital, gestational diabetes is managed through an integrated team approach that brings together obstetrics, diabetology, and dietetics within a single coordinated care framework.
Services for women with GDM include:
-
Early GDM screening for women with known risk factors, with OGTT available in-house and same-visit results.
-
Medical nutrition therapy provided by a dietitian experienced in GDM management in the Indian dietary context, delivering practical, culturally appropriate dietary guidance rather than generic advice.
-
Glucose monitoring support with instruction in self-monitoring technique and, where indicated, continuous glucose monitoring.
-
Specialist diabetology input for insulin initiation and dose management throughout pregnancy, with regular review as insulin requirements change in the third trimester.
-
Obstetric monitoring including serial growth scans to monitor for macrosomia, Doppler studies, and delivery planning that accounts for GDM-related obstetric risks.
-
Postpartum follow-up with OGTT at 6 to 12 weeks after delivery and a personalised plan for long-term diabetes risk reduction.
Managing GDM Is One of the Most Powerful Things You Can Do for Your Baby Right Now
Gestational diabetes is not a reflection of anything you did wrong. It is a physiological response to the demands of pregnancy that requires a specific, structured response. With the right team, the right guidance, and consistent attention to blood glucose targets, GDM is a highly manageable pregnancy condition.
Diagnosed with gestational diabetes or concerned about your blood sugar during pregnancy?
Chat with our care assistant for quick guidance and support and book a specialist GDM consultation at Dr. Humayun Speciality Hospital, T. Nagar, Chennai.
